Literature DB >> 8853227

Gallbladder motility in systemic sclerosis.

G Lock1, M Zeuner, M Kammerl, B Lang, J Schölmerich, A Holstege.   

Abstract

In 20 patients with systemic sclerosis (SSc) and 24 healthy controls, gallbladder motility was evaluated by abdominal ultrasonography after stimulation by a standard liquid meal. Results from patients with normal and disturbed oesophageal function were analysed separately in order to investigate the significance of gallbladder motility as a parameter for gastrointestinal involvement in SSc. All patients showed a marked decrease in gallbladder size after stimulation (patients 61 +/- 13%; controls 48 +/- 12%). Patients with oesophageal dysfunction (n = 12) had a slightly lower gallbladder contraction (maximal decrease = 58 +/- 13%) when compared to patients with normal oesophageal function (n = 8; 66 +/- 13%); however, this difference was not statistically significant. Gallbladder motility in patients with SSc was not reduced when compared with healthy controls. SSc-induced oesophageal dysfunction was not associated with impaired gallbladder motility. Thus, measurement of gallbladder emptying is not a helpful tool when looking for gastrointestinal involvement in SSc.

Entities:  

Mesh:

Year:  1996        PMID: 8853227     DOI: 10.1007/bf01816437

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  15 in total

1.  [Ultrasound evaluation of gallbladder function using planimetry].

Authors:  P Janowitz; W Swobodnik; J G Wechsler; S Hagel; H Ditschuneit
Journal:  Ultraschall Med       Date:  1990-06       Impact factor: 6.548

2.  Gallbladder vasculitis.

Authors:  K T Chen
Journal:  J Clin Gastroenterol       Date:  1989-10       Impact factor: 3.062

3.  Gastroesophageal reflux in esophageal scleroderma: diagnosis and implications.

Authors:  M B Orringer; L Dabich; C J Zarafonetis; H Sloan
Journal:  Ann Thorac Surg       Date:  1976-08       Impact factor: 4.330

4.  Systemic sclerosis and small bowel involvement.

Authors:  R Bluestone; M Macmahon; J M Dawson
Journal:  Gut       Date:  1969-03       Impact factor: 23.059

5.  Esophageal manometry in 95 healthy adult volunteers. Variability of pressures with age and frequency of "abnormal" contractions.

Authors:  J E Richter; W C Wu; D N Johns; J N Blackwell; J L Nelson; J A Castell; D O Castell
Journal:  Dig Dis Sci       Date:  1987-06       Impact factor: 3.199

6.  Diffuse systemic sclerosis with abnormal liver and gall bladder.

Authors:  P W Copeman; W E Medd
Journal:  Br Med J       Date:  1967-08-05

7.  [Volume of the functioning gallbladder and its emptying in patients with progressive systemic sclerosis].

Authors:  G Jonderko; W Koterla; A Końca; E J Kucharz; T Gołab; J Rubisz-Brzezińska; W Jedrocha; C Marcisz
Journal:  Pol Arch Med Wewn       Date:  1993-04

8.  The gastrointestinal manifestations of scleroderma: pathogenesis and management.

Authors:  S Cohen
Journal:  Gastroenterology       Date:  1980-07       Impact factor: 22.682

9.  Effect of erythromycin administration on upper gastrointestinal motility in scleroderma patients.

Authors:  S Fiorucci; E Distrutti; G Bassotti; R Gerli; S Chiucchiù; C Betti; L Santucci; A Morelli
Journal:  Scand J Gastroenterol       Date:  1994-09       Impact factor: 2.423

10.  Effect of erythromycin on gastric and gallbladder emptying and gastrointestinal symptoms in scleroderma patients is maintained medium term.

Authors:  S Fiorucci; E Distrutti; R Gerli; A Morelli
Journal:  Am J Gastroenterol       Date:  1994-04       Impact factor: 10.864

View more
  2 in total

1.  Gastrointestinal manifestations associated with systemic sclerosis: results from the nationwide inpatient sample.

Authors:  Yaseen Alastal; Tariq A Hammad; Anas Renno; Basmah Khalil; Joel Pierre; Bismark Kwaah; Sadik A Khuder; Ali Nawras
Journal:  Ann Gastroenterol       Date:  2017-06-30

2.  Gastrointestinal symptoms and motility disorders in patients with systemic scleroderma.

Authors:  Agostino Di Ciaula; Michele Covelli; Massimo Berardino; David Q H Wang; Giovanni Lapadula; Giuseppe Palasciano; Piero Portincasa
Journal:  BMC Gastroenterol       Date:  2008-02-27       Impact factor: 3.067

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.